Journal Zdravotnictví a medicína
29/10/2019
Potential of migrastatic therapy
The novel anticancer therapy developed by the research team from international centre Biocev in Prague could prevent cancer cells from forming
metastases. The migrastatic agents could thus become a fifth pillar in the
treatment of malignancies. More details were presented by the head of the
research team, associate professor Jan Brábek, PhD.
Journal Zdravotnicví a medicína, 2019/10; 29. 10. 2019; author:
MUDr. Andrea Skálová
..for the entire text, see here.
